C. Pak

J. Zerwekh, B. Reed, K. Sakhaee, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity.

G. Preminger, C. Pak, J. Harvey, 1985, The Journal of urology.

Long-term treatment of calcium nephrolithiasis with potassium citrate.

G. Preminger, K. Sakhaee, C. Pak, 1985, The Journal of urology.

Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects.

J. Zerwekh, P. García-Hernández, K. Sakhaee, 1994, The Journal of urology.

A simple apparatus for measurement of protein monofilm expansion at air-water interface in response to soluble reactants in the subsolution

C. Pak, J. Arnold, 1961 .

Urolithiasis : a medical and surgical reference

M. Resnick, C. Pak, 1990 .

The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism.

J. Zerwekh, N. Breslau, C. Pak, 1982, The Journal of clinical endocrinology and metabolism.

An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.

J. Zerwekh, J. Jowsey, C. Pak, 1979, The Journal of clinical endocrinology and metabolism.

Low urinary citrate excretion in nephrolithiasis.

C. Skurla, K. Sakhaee, C. Pak, 1983, Urology.

The potential role of salt abuse on the risk for kidney stone formation.

K. Sakhaee, P. Whitson, C. Pak, 1993, The Journal of urology.

Assessment of the pathogenetic role of physical exercise in renal stone formation.

K. Sakhaee, C. Pak, P. Snell, 1987, The Journal of clinical endocrinology and metabolism.

Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

B. Adams-Huet, K. Sakhaee, C. Pak, 1995, Annals of Internal Medicine.

Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.

A. Rousaud, P. Barceló, C. Pak, 1993, The Journal of urology.

Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.

G. Preminger, K. Sakhaee, C. Pak, 1988, The Journal of urology.

2147 EFFECT OF VARIOUS ANIMAL PROTEIN SOURCES ON URINARY STONE RISK FACTORS

Chad R. Tracy, M. Pearle, B. Adams-Huet, 2011 .

Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium.

C. Pak, D. Barilla, C. Notz, 1978, The American journal of medicine.

Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine.

J. Zerwekh, K. Sakhaee, C. Pak, 1986, The Journal of urology.

Detection of absorptive hypercalciuria type I without the oral calcium load test.

M. Pearle, K. Sakhaee, C. Pak, 2011, The Journal of urology.

Citraturic response to oral citric acid load.

K. Sakhaee, C. Pak, J. Poindexter, 1992, The Journal of urology.

Pharmacotherapy of kidney stones

C. Pak, 2008 .

Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.

G. Preminger, C. Skurla, K. Sakhaee, 1985, The Journal of urology.

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

M. Pearle, C. Pak, J. Poindexter, 2003, The Journal of urology.

Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria.

G. Preminger, C. Pak, Charles Y.C. Par, 1987, The Journal of urology.

Evidence for metabolic origin of absorptive hypercalciuria Type II

M. Pearle, K. Sakhaee, C. Pak, 2011, Urological Research.

Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism.

K. Sakhaee, C. Pak, S. Reddy, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CAUSES, PARATHYROID FUNCTIONS, AND DIAGNOSTIC CRITERIA

M. Ohata, C. Pak, W. Snyder, 1974 .

Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D.

S. Strowig, J. Zerwekh, J. Fordtran, 1981, The Journal of clinical investigation.

Etiology and treatment of urolithiasis.

C. Pak, Charles Y.C. Pak, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sequential Changes in Bone Density Before and After Parathyroidectomy in Primary Hyperparathyroidism

C. Pak, C. Pak, W. Snyder, 1982, Investigative radiology.

Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria.

N. Breslau, C. Pak, H. J. Heller, 1998, The Journal of urology.

Comparison of nonrandomized trials with slow‐release sodium fluoride with a randomized placebo‐controlled trial in postmenopausal osteoporosis

B. Adams-Huet, J. Ballard, N. Bell, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

PHOTON ABSORPTIOMETRIC ANALYSIS OF BONE DENSITY IN PRIMARY HYPERPARATHYROIDISM

R. Browne, C. Pak, C. Pak, 1975, The Lancet.

Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis.

J. Zerwekh, K. Sakhaee, C. Pak, 1997, The American journal of the medical sciences.

Original ArticlesSustained-Release Sodium Fluoride in the Management of Established Postmenopausal Osteoporosis

J. Zerwekh, K. Sakhaee, C. Pak, 1997 .

Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.

J. Zerwekh, P. Antich, K. Sakhaee, 1992, Bone and mineral.

Attainment of therapeutic fluoride levels in serum without major side effects using a slow‐release preparation of sodium fluoride in postmenopausal osteoporosis

J. Zerwekh, K. Sakhaee, C. Pak, 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria.

J. Zerwekh, C. Pak, H. J. Heller, 2007, Kidney international.

Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria

J. Zerwekh, K. Sakhaee, N. Breslau, 1992, Osteoporosis International.

Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys.

J. Zerwekh, K. Sakhaee, C. Pak, 1993, Bone and mineral.

Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.

J. Zerwekh, K. Sakhaee, C. Pak, 1989, The Journal of clinical endocrinology and metabolism.

The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.

K. Sakhaee, C. Pak, J. Poindexter, 1989, The Journal of urology.

Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

B. Adams-Huet, B. Adams-Huet, C. Pak, 1995, The American journal of medicine.

Partial biochemical and physicochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects.

J. Zerwekh, T. Kitamura, C. Pak, 1982, Kidney international.

Kidney stones: various forms and treatment.

C. Pak, 1979, Nephron.

A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias.

C. Pak, C. Pak, H. Bone, 1975, The New England journal of medicine.

The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus

P. Raskin, C. Pak, 1981, Diabetologia.

Pathogenesis of osteomalacia in secondary hyperparathyroidism after gastrectomy.

L. Deftos, F. Bartter, J. Wortsman, 1972, The American journal of medicine.

Effect of phenytoin on bone and vitamin D metabolism

J. Zerwekh, C. Pak, D. Barilla, 1979, Annals of neurology.

Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria.

B. Reed, K. Sakhaee, C. Pak, 1998, The Journal of clinical endocrinology and metabolism.

335‐base deletion in the mRNA coding for a dibasic amino acid transporter‐like protein (SLC3A1) isolated from a patient with cystinuria

B. Reed, C. Pak, W. Gitomer, 1998, Human mutation.

Recent advances in the biochemical and molecular biological basis of cystinuria.

C. Pak, W. Gitomer, 1996, The Journal of urology.

Treatment of vitamin D-resistant rickets with 25-hydroxycholecalciferol.

H. DeLuca, B. Frame, A. Simopoulos, 1972, Archives of internal medicine.

Effect of Growth Hormone Administration: Reciprocal Changes in Serum lα,25-Dihydroxyvitamin D and Intestinal Calcium Absorption*

J. Zerwekh, J. Marks, C. Pak, 1980 .

A simple and reliable method for calcium balance using combined period and continuous fecal markers.

P. Raskin, R. Galosy, C. Pak, 1980, Metabolism: clinical and experimental.

Jejunal absorption and secretion of calcium in patients with chronic renal disease on hemodialysis.

J. Fordtran, C. Pak, A. Hull, 1974, The Journal of clinical investigation.

Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.

A. Moses, N. Breslau, C. Pak, 1983, The Journal of clinical endocrinology and metabolism.

The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

M. Haussler, L. Deftos, C. Pak, 1977, The Journal of clinical investigation.

Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.

M. Haussler, J. Zerwekh, C. Pak, 1979, Journal of Clinical Endocrinology and Metabolism.

A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.

J. Zerwekh, N. Breslau, C. Pak, 1979, Journal of Clinical Endocrinology and Metabolism.

Approach to the patient with the first episode of nephrolithiasis

M. Cameron, C. Pak, 2004 .

Approach to the patient with recurrent neprolithiasis

M. Cameron, C. Pak, 2004 .

Citrate and renal calculi.

C. Pak, 1987, Mineral and electrolyte metabolism.

Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis

J. Zerwekh, K. Sakhaee, C. Pak, 1993, Osteoporosis International.

Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria.

G. Preminger, N. Breslau, C. Pak, 1992, The Journal of clinical endocrinology and metabolism.

An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.

J. Zerwekh, C. Pak, D. A. Norman, 1981, Metabolism: clinical and experimental.

Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.

C. Pak, M. Oata, 1974, Metabolism: clinical and experimental.

The effect of diphosphonate on calcium phosphate crystallization in urine in vitro.

C. Pak, M. Oata, 1973, Kidney international.

Effect of dietary modification on urinary stone risk factors.

M. Pearle, K. Sakhaee, C. Pak, 2005, Kidney international.

Contrasting effects of various potassium salts on renal citrate excretion.

H. Jacobson, K. Sakhaee, C. Pak, 1991, The Journal of clinical endocrinology and metabolism.

Evidence justifying a high fluid intake in treatment of nephrolithiasis.

C. Crowther, K. Sakhaee, C. Pak, 1980, Annals of internal medicine.

Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

K. Sakhaee, N. Breslau, C. Pak, 1980, The American journal of medicine.

The effect of ultraviolet B radiation treatments on calcium excretion and vitamin D metabolites in kidney stone formers.

J. Zerwekh, C. Pak, J. Williams, 1989, Clinical nephrology.

Dose dependency of calcium absorption: A comparison of calcium carbonate and calcium citrate

C. Pak, J. Harvey, M. Zobitz, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.

J. Zerwekh, K. Sakhaee, C. Pak, 1989, The Journal of clinical endocrinology and metabolism.

Medical stone management: 35 years of advances.

C. Pak, 2008, The Journal of urology.

Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.

J. Zerwekh, N. Breslau, C. Pak, 1980, The Journal of clinical endocrinology and metabolism.

Primary Hyperparathyroidism and Other Causes of Hypercalcemia

C. Pak, 1978 .

Lack of effect of salt intake on urinary uric acid excretion.

N. Breslau, C. Pak, 1983, The Journal of urology.

Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups.

J. Zerwekh, K. Sakhaee, C. Pak, 1983, The Journal of clinical endocrinology and metabolism.

Effect of 1,25-dihydroxyvitamin D3 on calcium absorption in the colon of healthy humans.

G. Krejs, C. Pak, W. Grinstead, 1984, The American journal of physiology.

Antihypertensive Comparison of Furosemide with Hydrochlorothiazide for Black Patients

C. Gomez-Sanchez, C. Pak, O. Holland, 1979 .

Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial.

N. Breslau, C. Pak, H. J. Heller, 1998, The Journal of urology.

Slow-Release Sodium Fluoride in the Management of Postmenopausal Osteoporosis

J. Reisch, B. Adams-Huet, K. Sakhaee, 1994, Annals of Internal Medicine.

The Effect of Intermittent Slow-Release Sodium Fluoride and Continuous Calcium Citrate Therapy on Calcitropic Hormones, Biochemical Markers of Bone Metabolism, and Blood Chemistry in Postmenopausal Osteoporosis

J. Zerwekh, C. Pak, P. Padalino, 1997, Calcified Tissue International.

Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.

K. Sakhaee, C. Pak, 1991, Bone and mineral.

Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting.

C. Pak, J. Poindexter, J. Harvey, 1990, Journal of the American College of Nutrition.

Calcium bioavailability from calcium carbonate and calcium citrate.

C. Pak, M. Nicar, Charlea Y.C. Pak, 1985, The Journal of clinical endocrinology and metabolism.

A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.

W. Snyder, J. Zerwekh, C. Pak, 1981, The Journal of clinical endocrinology and metabolism.

Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.

F. Murad, C. Pak, 1972, The New England journal of medicine.

Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.

L. Deftos, C. Pak, H. Bone, 1992, Henry Ford Hospital medical journal.

Ethnic and geographic diversity of stone disease.

M. Resnick, G. Preminger, C. Pak, 1997, Urology.

Impaired adaptation to salt-induced urinary calcium losses in postmenopausal osteoporosis.

K. Sakhaee, N. Breslau, C. Pak, 1985, Transactions of the Association of American Physicians.

Citrate and renal calculi: new insights and future directions.

C. Pak, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria.

J. Zerwekh, B. Reed, I. Nasonkin, 1995, The Journal of clinical endocrinology and metabolism.

Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma.

G. W. Smith, F. Bartter, C. Pak, 1968, The Journal of clinical endocrinology and metabolism.

Physiological basis for absorptive and renal hypercalciurias.

C. Pak, 1979, The American journal of physiology.

Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.

H. DeLuca, T. Suda, C. Pak, 1970, Archives of internal medicine.

Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis.

J. Zerwekh, K. Sakhaee, C. Pak, 1985, The Journal of clinical endocrinology and metabolism.

Simple Test for Hypercalciuria

G. Meadors, P. Miller, D. Sherrard, 1975 .

Magnesium bioavailability from magnesium citrate and magnesium oxide.

C. Pak, J. Poindexter, J. Lindberg, 1990, Journal of the American College of Nutrition.

A Simple and Reliable Test for the Diagnosis of Hyperparathyroidism

C. Pak, B. Ruskin, L. Sanzenbacher, 1972 .

PARATHYROID HORMONE AND THYROCALCITONIN: THEIR MODE OF ACTION AND REGULATION

C. Pak, 1971, Annals of the New York Academy of Sciences.

Jejunal and Ileal Calcium Absorption in Patients with Chronic Renal Disease

J. Fordtran, C. Pak, A. Hull, 2022 .

Vitamin D receptor quantitation in human blood mononuclear cells in health and disease

J. Zerwekh, S. Manolagas, N. Breslau, 1993, Molecular and Cellular Endocrinology.

Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.

H. DeLuca, J. Fordtran, C. Pak, 1976, Journal of Clinical Investigation.

Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum.

M. G. Kane, G. Krejs, J. Zerwekh, 1983, The American journal of medicine.

The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized placebo-controlled study.

K. Sakhaee, B. Adams-Huet, C. Pak, 1999, American journal of therapeutics.

Hypercalciuria and altered intestinal calcium absorption occurring independently of vitamin D in incomplete distal renal tubular acidosis.

G. Preminger, K. Sakhaee, C. Pak, 1987, Metabolism: clinical and experimental.

The solubility and synthetic rate of bone collagen in idiopathic osteoporosis.

F. Bartter, M. Lifschitz, C. Pak, 1972, Clinical orthopaedics and related research.

Renal stone risk factors in patients with type IV renal tubular acidosis.

J. Uribarri, C. Pak, M. Oh, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Medical management of nephrolithiasis in Dallas: update 1987.

C. Pak, 1988, The Journal of urology.

Erratum: Pharmacokinetic and Pharmacodynamic Comparison of Two Calcium Supplements in Postmenopausal Women (Journal of Clinical Pharmacology (Nov. 2000) 40:11 (1237-1244))

C. Pak, J. Poindexter, H. J. Heller, 2001 .

Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.

J. Zerwekh, C. Pak, K. Glass, 1980, The Journal of clinical endocrinology and metabolism.

Hydrochlorothiazide therapy in nephrolithiasis Effect on the urinary activity product and formation product of brushite

C. Pak, C. Pak, 1973, Clinical pharmacology and therapeutics.

Tumoral calcinosis: Evidence for concurrent defects in renal tubular phosphorus transport and in 1α,25-dihydroxycholecalciferol synthesis

J. Zerwekh, C. Pak, J. Townsend, 1980, Calcified Tissue International.

Administration of pharmacological amounts of 25(s),26-dihydroxyvitamin D3 reduces serum 1,25-dihydroxyvitamin D3 levels in rats.

J. Zerwekh, C. Pak, J. Harvey, 1987, Endocrinology.

Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias.

J. Zerwekh, C. Pak, 1980, Metabolism: clinical and experimental.

Comparison of semi-empirical and computer derived methods for estimating urinary saturation of brushite.

J. Zerwekh, B. Adams-Huet, O. Moe, 2009, The Journal of urology.

Medical therapy, calcium oxalate urolithiasis.

M. Pearle, C. Pak, L. Ruml, 1997, The Urologic clinics of North America.

Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.

G. Preminger, J. Reisch, K. Sakhaee, 1985, The American journal of medicine.

Medical management of nephrolithiasis.

C. Pak, 1982, The Journal of urology.

Is selective therapy of recurrent nephrolithiasis possible?

K. Sakhaee, N. Breslau, C. Pak, 1981, The American journal of medicine.

Successful management of uric acid nephrolithiasis with potassium citrate.

K. Sakhaee, C. Pak, C. Fuller, 1986, Kidney international.

Medical therapy and new approaches to management of urolithiasis.

M. Resnick, C. Pak, 2000, The Urologic clinics of North America.

Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.

G. Preminger, B. Adams-Huet, P. Whitson, 1995, The Journal of urology.

Effect of meal on the physiological and physicochemical actions of potassium citrate.

C. Pak, S. Baker, M. Oh, 1991, The Journal of urology.

Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.

C. Pak, P. Padalino, K. Koenig, 1991, The Journal of urology.

Prevention of Calcium Oxalate Renal Stones

C. Pak, 1989 .

Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.

C. Pak, J. Harvey, 1988, The Journal of urology.

Prevention of Recurrent Nephrolithiasis

C. Pak, 1987 .

Potassium Citrate Therapy of Nephrolithiasis

C. Pak, B. Adams, 1987 .

Augmentation of Renal Citrate Excretion by Oral Potassium Citrate Administration: Time Course, Dose Frequency Schedule, and Dose—Response Relationship

C. Skurla, K. Sakhaee, C. Pak, 1984, Journal of clinical pharmacology.

Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation.

J. Zerwekh, C. Pak, K. Holt, 1979, Investigative urology.

Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods.

C. Pak, B. Finlayson, Y. Hayashi, 1977, The Journal of laboratory and clinical medicine.

Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.

C. Pak, R. Peterson, 1986, Archives of internal medicine.

Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.

C. Pak, C. Fuller, Charles Y.C. Pak, 1986, Annals of internal medicine.

Decreased serum 24, 25‐dihydroxyvitamin D concentration during long‐term anticonvulsant therapy in adult epileptics

R. Homan, J. Zerwekh, C. Pak, 1982, Annals of neurology.

Extra-renal production of 24,25-dihydroxyvitamin D in chronic renal failure during 25 hydroxyvitamin D3 therapy.

J. Zerwekh, C. Pak, C. Pak, 1983, Kidney international.

Enhancement of renal excretion of uric acid during long-term thiazide therapy.

R. Galosy, C. Pak, A. Stewart, 1978, Investigative urology.

Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources.

Chad R. Tracy, M. Pearle, C. Tracy, 2014, The Journal of urology.

Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.

M. Pearle, B. Adams-Huet, E. Matsumoto, 2006, The Journal of urology.

Medical management of recurrent idiopathic nephrolithiasis

C. Pak, C. Odvina, 2006 .

Effect of dietary calcium on stone forming propensity.

B. Adams-Huet, M. Doerner, C. Pak, 2003, The Journal of urology.

Southwestern Internal Medicine Conference: medical management of nephrolithiasis--a new, simplified approach for general practice.

C. Pak, Charles Y.C. Pak, 1997, The American journal of the medical sciences.

Dietary management of idiopathic calcium urolithiasis.

M. Resnick, L. Smith, C. Pak, 1984, The Journal of urology.

Should patients with single renal stone occurrence undergo diagnostic evaluation?

C. Pak, 1982, The Journal of urology.

The spectrum and pathogenesis of hypercalciuria.

C. Pak, 1981, The Urologic clinics of North America.

Elucidation of factors determining formation of calcium phosphate stones.

B. Adams-Huet, C. Pak, 2004, The Journal of urology.

Assay of urinary oxalate: six methodologies compared.

J. Zerwekh, A. Hofmann, C. Pak, 1983, Clinical chemistry.

Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients.

C. Gomez-Sanchez, C. Pak, O. Holland, 1979, Archives of internal medicine.

EFFECT OF la-HYDROXYCHOLECALCIFEROL

J. Fordtran, C. Pak, A. Hull, 1975 .

Evidence for Absorption of Ionic Calcium and Soluble Calcium Complexes by the Duodenum and Cecum in the Rat

M. Favus, C. Pak, Charles Pak, 2001, American journal of therapeutics.

Effect of cranberry juice consumption on urinary stone risk factors.

K. Ogan, M. Pearle, B. Adams-Huet, 2005, The Journal of urology.

Citrate and renal calculi: an update.

C. Pak, 1994, Mineral and electrolyte metabolism.

Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro

C. Pak, M. Nicar, K. Hill, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.

K. Sakhaee, C. Pak, C. Fuller, 1983, Transactions of the Association of American Physicians.

Role of Medical Approach in the Management of Stone Disease

C. Pak, 1996, International journal of urology : official journal of the Japanese Urological Association.

Urinary reference values for stone risk factors in children.

G. Preminger, T. Kolon, C. Pak, 2008, The Journal of urology.

Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.

O. Moe, K. Sakhaee, C. Pak, 2005, The Journal of urology.

Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium Urate

C. Pak, L. Arnold, Leroy H. Arnold, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency.

G. Krejs, J. Zerwekh, J. Fordtran, 1983, Gastroenterology.

Kidney stones

C. Pak, 1998, The Lancet.

Prevention and treatment of kidney stones. Role of medical prevention.

C. Pak, 1989, The Journal of urology.

Familial absorptive hypercalciuria in a large kindred.

C. Pak, R. Peterson, M. Harrod, 1981, The Journal of urology.

Disturbances in mineral metabolism after successful renal transplantation.

J. Helderman, K. Sakhaee, C. Pak, 1985, Mineral and electrolyte metabolism.

Practical Guidelines for the Diagnosis and Management of Calcium Urolithiasis

C. Pak, 1978 .

Enhanced calcium bioavailability from a solubilized form of calcium citrate.

C. Pak, M. C. Hsu, J. Harvey, 1987, The Journal of clinical endocrinology and metabolism.

Effect of potassium magnesium citrate on thiazide-induced hypokalemia and magnesium loss.

C. Pak, L. Ruml, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Alkali absorption and citrate excretion in calcium nephrolithiasis

B. Adams-Huet, K. Sakhaee, B. Adams-Huet, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effect of 1,25-(OH)2D3 on jejunal absorption of magnesium in patients with chronic renal disease.

J. Zerwekh, J. Fordtran, C. Pak, 1980, The American journal of physiology.

Ionic interaction with bone mineral

C. Pak, E. Diller, 1969, Calcified Tissue Research.

Lack of skeletal lead accumulation during calcium citrate supplementation.

J. Zerwekh, C. Pak, 1998, Clinical chemistry.

Ionic interation with bone mineral: II. The control of Ca2+ and PO43−exchange by univalent cation-Ca2+ substitution at the hydroxyapatite crystal surface

F. Bartter, C. Pak, 1967 .

Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.

C. Pak, D. Barilla, C. Fetner, 1978, The Journal of urology.

The effect of polypeptide hormones on lipid monolayers. III. The effect of insulin, vasopressin, oxytocin, albumin, and prostaglandin E1 on the specific resistance to the evaporation of water through monomolecular films of monoöctadecyl phosphate, stearic acid, and stearyl alcohol

C. Pak, M. Kafka, 1972 .

Effect of sodium cellulose phosphate therapy on crystallization of calcium oxalate in urine.

C. Pak, R. Kaplan, Y. Hayashi, 1975, Metabolism: clinical and experimental.

Protein-protein interaction at the air-water interface

C. Pak, J. Arnold, 1962 .

The surface chemistry of monooctadecyl phosphate at the air/water interface. A study of molecular aggregation in monolayers.

N. Gershfeld, C. Pak, 1967, Journal of colloid and interface science.

Control of hypercalcemia with cellulose phosphate.

F. Bartter, J. Wortsman, C. Pak, 1968, The Journal of clinical endocrinology and metabolism.

The detection and removal of trace calcium from water for charged monolayer studies

N. Gershfeld, C. Pak, 1964 .

Effects of Polypeptide and Protein Hormones on Lipid Monolayers

C. Pak, M. Kafka, 1969, The Journal of general physiology.

A critical evaluation of treatment of calcium stones.

C. Pak, 1980, Advances in experimental medicine and biology.

Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation.

C. Pak, L. Brinkley, D. Barilla, 1978, The American journal of medicine.

Hyperoxaluric Calcium Urolithiasis

C. Pak, 1978 .

Idiopathic Renal Lithiasis: New Developments in Evaluation and Treatment

C. Pak, 1976 .

Potential etiologic role of brushite in the formation of calcium (renal) stones

C. Pak, 1981 .

Physical Chemistry of Stone Formation

C. Pak, 1978 .

Effects of cellulose phosphate and sodium phosphate on formation product and activity product of brushite in urine.

C. Pak, 1972, Metabolism: clinical and experimental.

Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria.

J. Fordtran, C. Pak, A. Hull, 1976, The Journal of clinical investigation.

Predictive value of kidney stone composition in the detection of metabolic abnormalities.

Beverley Adams-Huet, M. Pearle, B. Adams-Huet, 2003, The American journal of medicine.

Effect of diphosphonate on crystallization of calcium oxalate in vitro.

C. Pak, K. Holt, M. Ohata, 1975, Kidney international.

Biochemical and physicochemical presentations of patients with brushite stones.

C. Pak, J. Poindexter, R. Peterson, 2004, The Journal of urology.

Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.

J. Zerwekh, C. Pak, K. Hill, 1988, Kidney international.

Urinary glycosaminoglycans in normal subjects and patients with stones.

G. Preminger, C. Pak, J. Poindexter, 1988, The Journal of urology.

Rapid Communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate.

M. Pearle, B. Adams-Huet, O. Moe, 2004, Kidney international.

Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro.

T. Kitamura, C. Pak, 1982, The Journal of urology.

Enhancement of renal excretion of zinc by hydrochlorothiazide.

C. Pak, B. Ruskin, E. Diller, 1972, Clinica chimica acta; international journal of clinical chemistry.

C. Pak, K. Hill, J. Harvey, 1990, The Journal of lithotripsy & stone disease.

Renal oxalate excretion in calcium urolithiasis.

R. Galosy, C. Pak, L. Clarke, 1980, The Journal of urology.

Bone mineral content in patients with calcium urolithiasis.

C. Pak, R. Browne, S. Lawoyin, 1979, Metabolism: clinical and experimental.

Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.

C. Pak, F. Bartter, C. Delea, 1974, The New England journal of medicine.

Gastrointestinal calcium absorption in nephrolithiasis.

F. Bartter, C. Pak, C. Delea, 1972, The Journal of clinical endocrinology and metabolism.

Graphic display of urinary risk factors for renal stone formation.

C. Skurla, C. Pak, J. Harvey, 1985, The Journal of urology.

The measurement of intestinal calcium absorption by external radioisotope counting: application to study of nephrolithiasis.

R. Evens, F. Bartter, J. Wortsman, 1970, Clinical science.

Effect of the oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine.

F. Bartter, C. Pak, E. Powell, 1971, The American journal of medicine.

Calcification of collagen by urine in vitro: dependence on the degree of saturation of urine with respect to brushite.

C. Pak, B. Ruskin, 1970, The Journal of clinical investigation.

Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.

C. Pak, J. Harvey, M. Zobitz, 1985, The Journal of clinical endocrinology and metabolism.

A simple technique for the determination of urinary state of saturation with respect to brushite.

C. Pak, S. Chu, 1973, Investigative urology.

Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.

R. Galosy, C. Pak, 1980, The American journal of medicine.

Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy.

G. Preminger, J. W. Segura, C. Pak, 1995, The Journal of urology.

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism.

N. Breslau, C. Pak, K. Hill, 1988, The Journal of clinical endocrinology and metabolism.

Quantitation of response to therapy in calcium urolithiasis

J. Zerwekh, C. Pak, Olesegun Lawoyin, 1979, Urological Research.

Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards.

J. Zerwekh, C. Pak, H. Bone, 1979, The Journal of urology.

Sodium cellulose phosphate: mechanism of action and effect on mineral metabolism.

C. Pak, 1973, The Journal of clinical pharmacology and new drugs.

Bioavailability of Citrate from Two Different Preparations of Potassium Citrate

C. Pak, J. Harvey, M. Zobitz, 1989, Journal of clinical pharmacology.

Medical Management of Urinary Stone Disease

C. Pak, 2004, Nephron Clinical Practice.

A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.

C. Pak, 1981, Investigative urology.

CHAPTER 27 – Nephrolithiasis in Primary Hyperparathyroidism

M. Favus, C. Pak, V. Klugman, 2001 .

The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.

C. Pak, M. Nicar, C. Northcutt, 1982, Contributions to nephrology.

Theme Poster Session: Inhibitors II

C. Pak, J. Sallis, 1989 .

Calcium Urolithiasis: Pathogenesis, Diagnosis, and Management

C. Pak, 1978 .

Effects of orthophosphate therapy on the crystallization of calcium salts in urine

J. Zerwekh, C. Pak, K. Holt, 1978 .

Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.

C. Pak, M. Nicar, R. Peterson, 1984, The Journal of urology.

Assessment of pathogenetic roles of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis

C. Pak, K. Holt, F. Britton, 1980 .

Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.

J. Zerwekh, C. Pak, L. Brinkley, 1978, The American journal of medicine.

Ionic interaction with bone mineral. IV. Varying affinity of synthetic calcium phosphates for Ca2+.

H. Skinner, C. Pak, 1968, Biochimica et biophysica acta.

Biochemical profile of idiopathic uric acid nephrolithiasis.

W. Frawley, K. Sakhaee, C. Pak, 2001, Kidney international.

Seasonal variations in urinary risk factors among patients with nephrolithiasis.

C. Pak, K. Hill, J. Poindexter, 1991, The Journal of lithotripsy & stone disease.

Mechanisms of hypercalciuria.

J. Zerwekh, C. Pak, 1949, Pathobiology annual.

Ionic interaction with bone mineral. I. Evidence for an isoionic calcium exchange with hydroxyapatite.

F. Bartter, C. Pak, 1967, Biochimica et biophysica acta.

Hyperuricosuric Calcium Urolithiasis

C. Pak, 1978 .

Clinical Pharmacology of Sodium Cellulose Phosphate

C. Pak, C. Pak, 1979, Journal of clinical pharmacology.

Metastable supersaturation. Physicochemical studies provide new insights into formation of renal and biliary tract stones.

C. Pak, R. Holzbach, 1974, The American journal of medicine.

Normocalcemic primary hyperparathyroidism.

W. Hammond, F. Bartter, C. Pak, 1969, The American journal of medicine.

Renal Stones of Calcium Phosphate

G. W. Smith, C. Pak, E. Diller, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Objective Evidence for the Beneficial Effect of a High Fluid Intake in the Management of Nephrolithiasis

J. Zerwekh, K. Sakhaee, C. Pak, 1981 .

Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.

C. Pak, A. Woelfel, R. Kaplan, 1977, Metabolism: clinical and experimental.

Fasting urinary calcium and adenosine 3',5'-monophosphate: a discriminant analysis for the identification of renal and absorptive hypercalciurias.

R. Galosy, C. Pak, 1979, The Journal of clinical endocrinology and metabolism.

Selective effects of thiazide on intestinal absorption of calcium and adsorptive and renal hypercalciurias.

C. Pak, R. Kaplan, D. Barilla, 1978, Metabolism: clinical and experimental.

Calcium urolithiasis: Is it analogous to bone formation?

C. Pak, 1978, Calcified Tissue Research.

Intestinal Absorption of Calcium, Magnesium, Phosphate and Oxalate: Deviation from Normal in Idiopathic Urolithiasis

G. Krejs, C. Pak, M. Nicar, 1985 .

Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria.

J. Fordtran, C. Pak, P. Brannan, 1979, The American journal of medicine.

Factors affecting absorbability of calcium from calcium salts and food

L. Avioli, C. Pak, 1988, Calcified Tissue International.

Measurement of mechanical properties of bone material in vitro by ultrasound reflection: Methodology and comparison with ultrasound transmission

R. C. Murry, J A Anderson, R B Ashman, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The effect of polypeptide hormones on lipid monolayers. ii. The effect of insulin analogues, vasopressin, oxytocin, thyrocalcitonin, adrenocorticotropin, and 3',5'-cyclic AMP on the uptake of Ca2+ by monomolecular films of monooctadecyl phosphate.

C. Pak, M. Kafka, 1969, Biochimica et biophysica acta.

Interaction of soluble proteins with protein monolayers

C. Pak, J. Arnold, 1968, Journal of the American Oil Chemists' Society.

The treatment of osteoporosis with calcium infusions. Clinical studies.

J. Jowsey, R. Evens, F. Bartter, 1969, The American journal of medicine.

The treatment of osteoporosis with calcium infusions. Evaluation of bone biopsies.

J. Jowsey, C. Pak, R. Hoye, 1969, The American journal of medicine.

Polypeptide hormones and lipid monolayers

C. Pak, M. Kafka, 2007 .

Use of cyclic nucleotides in detection of disturbed parathyroid function.

C. Pak, 1980, Advances in cyclic nucleotide research.

Renal stone risk assessment during Space Shuttle flights.

R. Pietrzyk, P. Whitson, C. Pak, 1997, The Journal of urology.

Diagnosis of hyperparathyroidism.

C. Pak, H. Bone, W. Snyder, 1977, Annual review of medicine.

The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal.

G. Preminger, C. Pak, R. Peterson, 1985, The Journal of urology.

Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia.

J. Melnick, K. Sakhaee, C. Pak, 1998, Kidney international.

Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism.

C. Pak, W. Snyder, R. Kaplan, 1976, The Journal of clinical endocrinology and metabolism.

Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24.

B. Reed, C. Pak, W. Gitomer, 1999, The Journal of clinical endocrinology and metabolism.

Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.

C. Roehrborn, M. Pearle, C. Pak, 1999, Journal of endourology.

Nephrolithiasis from calcium supplementation.

G. Preminger, K. Sakhaee, C. Pak, 1987, The Journal of urology.

The practical evaluation and selective medical management of nephrolithiasis.

G. Preminger, C. Pak, 1985, Seminars in urology.

Dietary sulfate regulates the expression of the renal brush border Na/Si cotransporter NaSi-1.

M. Levi, K. Sakhaee, C. Pak, 1998, Journal of the American Society of Nephrology : JASN.

T H E MEASUREMENT OF INTESTINAL CALCIUM ABSORPTION BY EXTERNAL RADIOISOTOPE

R. Evens, C. Pak, E. Zisman, 2012 .

The preservation of urine samples for determination of renal stone risk factors.

M. Hsu, C. Pak, M. Nicar, 1987, Laboratory medicine.

Peptide hormones at cell membranes: Studies in a model system

C. Pak, M. Kafka, 1972 .

Preparation of the mineral phase of bone using ethylenediamine extraction

H. Skinner, E. Kempner, C. Pak, 2005, Calcified Tissue Research.

Modification by food of the calcium absorbability and physicochemical effects of calcium citrate.

C. Pak, C. L. Wabner, 1992, Journal of the American College of Nutrition.

Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus.

S. Grundy, A. Garg, R. Unger, 1990, The Journal of clinical endocrinology and metabolism.

Effect of prolonged bedrest on the propensity for renal stone formation.

C. Pak, K. Hill, T. Hwang, 1988, The Journal of clinical endocrinology and metabolism.

Critical appraisal of oral calcium load test for indirect assessment of intestinal calcium absorption.

K. Sakhaee, C. Pak, R. Peterson, 1979, Urology.

Utility and limitation of calciuric response to oral calcium load as a measure of intestinal calcium absorption: comparison with isotopic fractional calcium absorption.

J. Zerwekh, K. Sakhaee, C. Pak, 1981, Investigative urology.

Diagnostic Procedures in Disorders of Calcium Metabolism.

F. Bartter, C. Pak, E. Zisman, 1967 .

Chloride/phosphorus in primary hyperparathyroidism.

C. Pak, J. Townsend, 1976, Annals of internal medicine.

Treatment of idiopathic calcium stone disease

C. Pak, W. Robertson, B. Danielson, 1983, Calcified Tissue International.

Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteers.

D. Brater, K. Sakhaee, C. Pak, 1985, The Journal of urology.

Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts.

C. Pak, K. Hill, R. Browne, 1983, The Journal of clinical endocrinology and metabolism.

An exaggerated augmentation of renal calcium excretion after oral glucose ingestion in patients with renal hypercalciuria.

C. Pak, D. Barilla, J. Townsend, 1978, Investigative urology.

Fibrogenesis imperfecta ossium. A collagen defect causing osteomalacia.

H. Frost, W. Reynolds, C. Pak, 1971, The New England journal of medicine.

Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.

J. Zerwekh, K. Sakhaee, C. Pak, 1994, Bone.

Effect of added citrate or malate on calcium absorption from calcium-fortified orange juice.

C. Pak, S. Haynes, A. Stewart, 1994, Journal of the American College of Nutrition.

Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria.

D. Brater, K. Sakhaee, C. Pak, 1985, The Journal of clinical endocrinology and metabolism.

The role of parathyroid hormone in the gastro-intestinal absorption of calcium.

F. Bartter, J. Wortsman, C. Pak, 1970, Clinical science.

Gastrointestinal citrate absorption in nephrolithiasis.

C. Pak, J. Poindexter, R. Khan, 1992, The Journal of urology.

Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.

J. Li, B. Adams-Huet, H. Genant, 2001, Archives of internal medicine.

Quantitation of incident spinal fractures: comparison of visual detection with quantitative morphometry.

K. Sakhaee, C. Pak, J. Poindexter, 1996, Bone.

Treatment of osteoporosis with calcium infusions.

F. Bartter, C. Pak, 1972, Seminars in drug treatment.

Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.

C. Pak, 1979, Investigative urology.

Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney.

N. Breslau, C. Pak, M. O'Neill, 1981, JAMA.

Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials.

C. Pak, 2000, Clinical nephrology.

Aromatase Deficiency Causes Altered Expression of Molecules Critical for Calcium Reabsorption in the Kidneys of Female Mice

J. Zerwekh, M. Kuro-o, R. Bindels, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Renal effects of porcine thyrocalcitonin in the dog.

C. Pak, B. Ruskin, A. Casper, 1970, Endocrinology.

Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism.

C. Pak, M. Nicar, 1982, Mineral and electrolyte metabolism.

Ionic interaction with bone mineral VI response of the calcium phosphate mineral to calcifying solutions.

H. Skinner, C. Pak, 1975, Bioinorganic chemistry.

Reductions in bone strength after fluoride treatment are not reflected in tissue-level acoustic measurements.

J. Zerwekh, P. Antich, C. Pak, 1997, Bone.

Increased circulating 1α,25 dihydroxyvitamin D3 in patients with primary hyperparathyroidism

M. Haussler, C. Pak, H. Bone, 1975 .

Ionic Interaction with Bone Mineral. III. Reversible Calcium Exchange with Bone Powder

F. Bartter, C. Pak, 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.